These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1328 related articles for article (PubMed ID: 7693849)

  • 1. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions.
    Van den Eertwegh AJ; Noelle RJ; Roy M; Shepherd DM; Aruffo A; Ledbetter JA; Boersma WJ; Claassen E
    J Exp Med; 1993 Nov; 178(5):1555-65. PubMed ID: 7693849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39.
    Foy TM; Shepherd DM; Durie FH; Aruffo A; Ledbetter JA; Noelle RJ
    J Exp Med; 1993 Nov; 178(5):1567-75. PubMed ID: 7693850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo T-B cell interactions and cytokine-production in the spleen.
    van den Eertwegh AJ; Laman JD; Noelle RJ; Boersma WJ; Claassen E
    Semin Immunol; 1994 Oct; 6(5):327-36. PubMed ID: 7532461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo gp39-CD40 interactions occur in the non-follicular compartments of the spleen and are essential for thymus dependent antibody responses and germinal center formation.
    van den Eertwegh AJ; Van Meurs M; Foy TM; Noelle RJ; Boersma WJ; Claassen E
    Adv Exp Med Biol; 1994; 355():75-80. PubMed ID: 7535976
    [No Abstract]   [Full Text] [Related]  

  • 5. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory.
    Foy TM; Laman JD; Ledbetter JA; Aruffo A; Claassen E; Noelle RJ
    J Exp Med; 1994 Jul; 180(1):157-63. PubMed ID: 7516405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency.
    Farrington M; Grosmaire LS; Nonoyama S; Fischer SH; Hollenbaugh D; Ledbetter JA; Noelle RJ; Aruffo A; Ochs HD
    Proc Natl Acad Sci U S A; 1994 Feb; 91(3):1099-103. PubMed ID: 7508119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An essential role for gp39, the ligand for CD40, in thymic selection.
    Foy TM; Page DM; Waldschmidt TJ; Schoneveld A; Laman JD; Masters SR; Tygrett L; Ledbetter JA; Aruffo A; Claassen E; Xu JC; Flavell RA; Oehen S; Hedrick SM; Noelle RJ
    J Exp Med; 1995 Nov; 182(5):1377-88. PubMed ID: 7595208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody to gp39, the ligand for CD40 significantly inhibits the humoral response from Graves' thyroid tissues xenografted into severe combined immunodeficient (SCID) mice.
    Resetkova E; Kawai K; Enomoto T; Arreaza G; Togun R; Foy TM; Noelle RJ; Volpé R
    Thyroid; 1996 Aug; 6(4):267-73. PubMed ID: 8875745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis.
    Mohan C; Shi Y; Laman JD; Datta SK
    J Immunol; 1995 Feb; 154(3):1470-80. PubMed ID: 7529804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regulation of T cell-dependent antibody formation in vitro by CD40 ligand and IL-2.
    Grabstein KH; Maliszewski CR; Shanebeck K; Sato TA; Spriggs MK; Fanslow WC; Armitage RJ
    J Immunol; 1993 Apr; 150(8 Pt 1):3141-7. PubMed ID: 7682232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of residues on CD40 and its ligand which are critical for the receptor-ligand interaction.
    Bajorath J; Chalupny NJ; Marken JS; Siadak AW; Skonier J; Gordon M; Hollenbaugh D; Noelle RJ; Ochs HD; Aruffo A
    Biochemistry; 1995 Feb; 34(6):1833-44. PubMed ID: 7531493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions.
    Oxenius A; Campbell KA; Maliszewski CR; Kishimoto T; Kikutani H; Hengartner H; Zinkernagel RM; Bachmann MF
    J Exp Med; 1996 May; 183(5):2209-18. PubMed ID: 8642330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of B cells by 1 microm particulate lysozyme or peptides: a Th-dependent pathway requiring CD40-CD40 ligand interaction.
    Sedlik C; Rojas M; Leclerc C
    Int Immunol; 1998 Aug; 10(8):1111-9. PubMed ID: 9723697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40.
    Durie FH; Fava RA; Foy TM; Aruffo A; Ledbetter JA; Noelle RJ
    Science; 1993 Sep; 261(5126):1328-30. PubMed ID: 7689748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular basis for T cell help in humoral immunity: CD40 and its ligand, gp39.
    Marshall LS; Aruffo A; Ledbetter JA; Noelle RJ
    J Clin Immunol; 1993 May; 13(3):165-74. PubMed ID: 7686564
    [No Abstract]   [Full Text] [Related]  

  • 16. Synergistic effects of the xid gene in X chromosome congenic mice. I. Inability of C3.CBA/N mice to respond to thymus-dependent antigens in adoptive transfer assays.
    Kenny JJ; Guelde G; Hansen C; Mond JJ
    J Immunol; 1987 Mar; 138(5):1363-71. PubMed ID: 2949014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential requirements for expression of CD80/86 and CD40 on B cells for T-dependent antibody responses in vivo.
    Lumsden JM; Williams JA; Hodes RJ
    J Immunol; 2003 Jan; 170(2):781-7. PubMed ID: 12517941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome.
    Aruffo A; Farrington M; Hollenbaugh D; Li X; Milatovich A; Nonoyama S; Bajorath J; Grosmaire LS; Stenkamp R; Neubauer M
    Cell; 1993 Jan; 72(2):291-300. PubMed ID: 7678782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells.
    Noelle RJ; Roy M; Shepherd DM; Stamenkovic I; Ledbetter JA; Aruffo A
    Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6550-4. PubMed ID: 1378631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of antigen-specific CD4+ effector T cells in vivo: immunization results in a transient population of MEL-14-, CD45RB- helper cells that secretes interleukin 2 (IL-2), IL-3, IL-4, and interferon gamma.
    Bradley LM; Duncan DD; Tonkonogy S; Swain SL
    J Exp Med; 1991 Sep; 174(3):547-59. PubMed ID: 1678774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 67.